Does stress influence the course of rheumatic diseases?

Clinical and Experimental Rheumatology

Volumn 24, Issue 3, 2006, Pages 225-228

  Straub, Rainer H ^a   Cutolo, Maurizio ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; GLUCOCORTICOID; HYDROCORTISONE; INTERLEUKIN 2; INTERLEUKIN 6; NEUROTRANSMITTER; NORADRENALIN; TUMOR NECROSIS FACTOR;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN CORTEX; CLINICAL PRACTICE; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE REGIMEN; EXERCISE; FREQUENCY ANALYSIS; HUMAN; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; LIFE EVENT; MENTAL STRESS; NEUROTRANSMISSION; NOCICEPTION; PATHOGENESIS; PHYSICIAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATIC DISEASE;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; ARTHRITIS, RHEUMATOID; COGNITIVE THERAPY; DISEASE MODELS, ANIMAL; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; STRESS, PSYCHOLOGICAL;

EID: 33746645498     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. HERRMANN M, SCHÖLMERICH J, STRAUB RH: Stress and rheumatic diseases. Rheum Dis Clin North Am 2000; 26: 8-1-8-27.
2. ZAUTRA AJ, HOFFMAN J, POTTER P, MATT KS, YOCUM D, CASTRO L: Examination of changes in interpersonal stress as a factor in disease exacerbations among women with rheumatoid arthritis. Ann Behav Med 1997; 19: 279-86.
3. ZAUTRA AJ, HOFFMAN JM, MATT KS et al.: An examination of individual differences in the relationship between interpersonal stress and disease activity among women with rheumatoid arthritis [In Process Citation]. Arthritis Care Res 1998; 11: 271-9.
4. FEIGENBAUM SL, MASI AT, KAPLAN SB: Prognosis in rheumatoid arthritis : a longitudinal study of newly diagnosed younger adult patients. Am J Med 1979: Prognosis in rheumatoid arthritis : a longitudinal study of newly diagnosed younger adult patients 1979. Am J Med 1979; 66: 377-84.
5. DEKKERS JC, GEENEN R, EVERS AW, KRAAIMAAT FW, BIJLSMA JW, GODAERT GL: Biopsychosocial mediators and moderators of stress-health relationships in patients with recently diagnosed rheumatoid arthritis. Arthritis Rheum 2001; 45: 307-16.
6. MUNCK A, GUYRE PM: Glucocorticoid physiology, pharmacology and stress. Adv Exp Med Biol 1986; 196: 81-96.
7. WEBSTER JI, TONELLI L, STERNBERG EM: Neuroendocrine regulation of immunity. Annu Rev Immunol 2002; 20:125-63.
8. BUTTGEREIT F, STRAUB RH, WEHLING M, BURMESTER GR: Glucocorticoids in the treatment of rheumatic diseases: An update on mechanisms of action. Arthritis Rheum 2004; in press:
9. COOPER DA, DUCKETT M, PETTS V, PENNY R: Corticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes. Clin Exp Immunol 1979; 37:145-51.
10. WIEGERS GJ, LABEUR MS, STEC IE, KLINKERT WE, HOLSBOER F, REUL JM: Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. J Immunol 1995; 155: 1893-902.
11. BROUG-HOLUB E, KRAAL G: Dose- and time-dependent activation of rat alveolar macrophages by glucocorticoids. Clin Exp Immunol 1996; 104: 332-6.
12. BARBER AE, COYLE SM, MARANO MA et al.: Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993; 150:1999-2006.
13. DHABHAR FS, McEWEN BS: Bidirectional effects of stress and glucocorticoid hormones on immune function: possible explanations for paradoxical observations. In: ADER R, FELTEN DL, COHEN N (Eds.): Psychoneuroimmunology. San Diego, Academic Press, 2001: 301-38.
14. MADDEN KS: Catecholamines, sympathetic nerves, and immunity. In: ADER R, FELTEN DL, COHEN N (Eds.): Psychoneuroimmunology. San Diego, Academic Press, 2001: 197-216.
15. SPENGLER RN, CHENSUE SW, GIACHERIO DA, BLENK N, KUNKEL SL: Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J Immunol 1994; 152: 3024-31.
16. YANG S, ZHOU M, CHAUDRY IH, WANG P: Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1014-G1021.
17. RENAULD AE, SPENGLER RN: Tumor necrosis factor expressed by primary hippocampal neurons and SH-SY5Y cells is regulated by alpha(2)-adrenergic receptor activation. J Neurosci Res 2002; 67: 264-74.
18. LAPPIN D, WHALEY K: Adrenergic receptors on monocytes modulate complement component synthesis. Clin Exp Immunol 1982; 47: 606-12.
19. STRAUB RH, GÜNZLER C, MILLER LE, CUTOLO M, SCHÖLMERICH J, SCHILL S: Anti-inflammatory cooperativity of corticosteroids and norepinephrine in rheumatoid arthritis synovial tissue in vivo and in vitro. FASEB J 2002; 16: 993-1000.
20. CROFFORD LJ, KALOGERAS KT, MASTORAKOS G et al.: Circadian relationships between interleukin (IL)-6 and hypothalamic- pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 1997; 82: 1279-83.
21. CUTOLO M, FOPPIANI L, PRETE C et al.: Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999; 26:282-8.
22. STRAUB RH, PONGRATZ G, SCHÖLMERICH J et al.: Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. Arthritis Rheum 2003; 48: 1504-12.
23. NEECK G, FEDERLIN K, GRAEF V, RUSCH D, SCHMIDT KL: Adrenal secretion of cortisol in patients with rheumatoid arthritis. J Rheumatol 1990; 17: 24-9.
24. DEKKERS JC, GEENEN R, GODAERT GL et al.: Experimentally challenged reactivity of the hypothalamic pituitary adrenal axis in patients with recently diagnosed rheumatoid arthritis. J Rheumatol 2001; 28:1496-504.
25. EIJSBOUTS AM, Van den HOOGEN FH, LAAN RF, HERMUS AR, SWEEP CG, Van de PUTTE LB: Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 658-64.
26. + T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics. Rheumatology (Oxford) 2004; 43: 43-8.
27. HARBUZ MS, KORENDOWYCH E, JESSOP DS, CROWN AL, LI PDFAN SL, KIRWAN JR: Hypothalamo-pituitary-adrenal axis dysregulation in patients with rheumatoid arthritis after the dexamethasone/corticotrophin releasing factor test. J Endocrinol 2003; 178: 55-60.
28. STRAUB RH, KITTNER JM, HEIJNEN C, SCHEDLOWSKI M, SCHMIDT RE, JACOBS R: Infusion of epinephrine decreases serum levels of cortisol and 17-hydroxyprogesterone in patients with rheumatoid arthritis. J Rheumatol 2002; 29: 1659-64.
29. BAERWALD C, GRAEFE C, Von WICHERT P, KRAUSE A: Decreased density of beta-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J Rheumatol 1992; 19: 204-10.
30. HEIJNEN CJ, ROUPPE VD, V, WULFFRAAT N, Van der NJ, KUIS W, KAVELAARS A: Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J Neuroimmunol 1996; 71: 223-6.
31. MILLER LE, JÜSTEN HP, SCHÖLMERICH J, STRAUB RH: The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J 2000; 14: 2097-107.
32. SCHAIBLE HG, GRUBB BD: Afferent and spinal mechanisms of joint pain. Pain 1993; 55: 5-54.
33. CUTOLO M, SULLI A, SERIOLO B, ACCARDO S, MASI AT: Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13: 217-26.
34. ROVENSKY J, KVETNANSKY R, RADIKOVA Z et al.: Hormone concentrations in synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 292-6.
35. ROUPE Van der VOORT C, HEIJNEN CJ, WULFFRAAT N, KUIS W, KAVELAARS A: Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for alpha(1)-adrenergic receptors. J Neuroimmunol 2000; 110: 223-9.
36. HIRANO D, NAGASHIMA M, OGAWA R, YOSHINO S: Serum levels of interleukin 6 and stress related substances indicate mental stress condition in patients with rheumatoid arthritis. J Rheumatol 2001; 28: 490-5.
37. KITTNER JM, JACOBS R, PAWLAK CR, HEIJNEN CJ, SCHEDLOWSKI M, SCHMIDT RE: Adrenaline-induced immunological changes are altered in patients with rheumatoid arthritis. Rheumatology (Oxford) 2002; 41: 1031-9.
38. MARCENARO M, PRETE C, BADINI A, SULLI A, MAGI E, CUTOLO M: Rheumatoid arthritis, personality, stress response style, and coping with illness. A preliminary survey. Ann N Y Acad Sci 1999; 876:419-25.: 419-25.
39. WALKER JG, LITTLEJOHN GO, MCMURRAY NE, CUTOLO M: Stress system response and rheumatoid arthritis: a multilevel approach. Rheumatology (Oxford) 1999; 38: 1050-7.
40. PARKER JC, SMARR KL, BUCKELEW SP et al.: Effects of stress management on clinical outcomes in rheumatoid arthritis. Arthritis Rheum 1995; 38: 1807-18.
41. MULTON KD, PARKER JC, SMARR KL et al.: Effects of stress management on pain behavior in rheumatoid arthritis. Arthritis Rheum 2001; 45: 122-8.